semaglutide pdr GLP-1 Drugs and Diabetic Eye Disease: Ozempic, Semaglutide, and Retinopathy Risk FBI warns about counterfeit weight

It is a 31-amino-acid linear peptide engineered with targeted substitutions and a C18 fatty diacid side chain conjugated to the -amino group of Lys26 , a modification studied for its role in enhancing metabolic stability and prolonging systemic persistence in research models

It can also be part of a treatment plan for weight loss in people who are overweight or obese

They say that: If patients experience a sudden loss of vision or rapidly worsening eyesight during treatment with semaglutide, they should contact their doctor without delay

Semaglutide acts as a receptor agonist, mimicking the GLP-1 hormone that regulates appetite and insulin production